Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Reevaluation of Makuuchi’s criteria for resecting hepatocellular carcinoma: A Japanese nationwide survey
Osamu Aramaki, Tadatoshi Takayama, Yutaka Matsuyama, Shoji Kubo, Norihiro Kokudo, Masayuki Kurosaki, Takamichi Murakami, Shuichiro Shiina, Masatoshi Kudo, Michiie Sakamoto, Osamu Nakashima, Takumi Fukumoto, Hiroko Iijima, Susumu Eguchi, Yuji Soejima, Masatoshi Makuuchi (2022). Reevaluation of Makuuchi’s criteria for resecting hepatocellular carcinoma: A Japanese nationwide survey. , 53(2), DOI: https://doi.org/10.1111/hepr.13844.
Article19 days agoCurrent status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)
Kazuya Okushin, Ryosuke Tateishi, Arata Takahashi, Koji Uchino, Ryo Nakagomi, T. Nakatsuka, Tatsuya Minami, Masaya Sato, Mitsuhiro Fujishiro, Kiyoshi Hasegawa, Yuichiro Eguchi, Tatsuya Kanto, Shoji Kubo, Hitoshi Yoshiji, Hiroaki Miyata, Namiki Izumi, Masatoshi Kudo, Kazuhiko Koike (2022). Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL). , 57(8), DOI: https://doi.org/10.1007/s00535-022-01893-5.
Article19 days agoFinal results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis.
Masatoshi Kudo, Kazuomi Ueshima, Shin Nakahira, Naoshi Nishida, Hiroshi Ida, Yasunori Minami, Takuya Nakai, Hiroshi Wada, Shoji Kubo, Kazuyoshi Ohkawa, Asahiro Morishita, Takeo Nomi, Koji Ishida, Shogo Kobayashi, Makoto Umeda, Masakatsu Tsurusaki, Yasutaka Chiba, Kenichi Yoshimura, Kazuko Sakai, Kazuto Nishio (2022). Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis.. , 40(4_suppl), DOI: https://doi.org/10.1200/jco.2022.40.4_suppl.416.
Article19 days agoLiver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma
Shoji Kubo, Hiroji Shinkawa, Yoshinari Asaoka, Tatsuya Ioka, Hiroshi Igaki, Namiki Izumi, Takao Itoi, Michiaki Unno, Masayuki Ohtsuka, Takuji Okusaka, Masumi Kadoya, Masatoshi Kudo, Takashi Kumada, Norihiro Kokudo, Michiie Sakamoto, Yoshihiro Sakamoto, Hideyuki Sakurai, Tadatoshi Takayama, Osamu Nakashima, Yasushi Nagata, Etsuro Hatano, Kenichi Harada, Takamichi Murakami, Masakazu Yamamoto (2022). Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma. , 11(4), DOI: https://doi.org/10.1159/000522403.
Article19 days agoEffect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation
Yoshikuni Kawaguchi, Kiyoshi Hasegawa, Yasuhiro Hagiwara, Mario De Bellis, Simone Famularo, Elena Panettieri, Yutaka Matsuyama, Ryosuke Tateishi, Tomoaki Ichikawa, Takashi Kokudo, Namiki Izumi, Shoji Kubo, Michiie Sakamoto, Shuichiro Shiina, Tadatoshi Takayama, Osamu Nakashima, Takamichi Murakami, Jean‐Nicolas Vauthey, Felice Giuliante, Luciano De Carlis, Fabrizio Romano, Andrea Ruzzenente, Alfredo Guglielmi, Masatoshi Kudo, Norihiro Kokudo (2021). Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation. , 116(8), DOI: https://doi.org/10.14309/ajg.0000000000001256.
Article19 days ago